Amyris Finalizes Cannabinoid Development, Licensing and Commercialization Agreement Containing $300 Million of R&D and Milestone Payments and a Long-Term Royalty Stream

0
305


Amyris Finalizes Cannabinoid Development, Licensing and Commercialization Agreement Containing $300 Million of R&D and Milestone Payments and a Long-Term Royalty Stream – Cosmetics & Beauty Industry Today – EIN News

Trusted News Since 1995

A service for beauty industry professionals
·
Monday, March 18, 2019

·
479,636,267
Articles


·
3+ Million Readers

News Monitoring and Press Release Distribution Tools

Press Releases

Events & Conferences




Source link

LAISSER UN COMMENTAIRE

Please enter your comment!
Please enter your name here